rtl1000
Recombinant proteinexperimental
Clinical trial activity
1 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2006 (NCT00411723)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- rtl1000
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00411723 | Phase 1 | Dec 1, 2006 | Artielle ImmunoTherapeutics, EvergreenHealth, Indiana University, Oregon Health and Science University, University of Kansas, University of Maryland, Yale University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Artielle ImmunoTherapeutics | For profit | 1 | 1 | 1 | 2006 |
| EvergreenHealth | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Indiana University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Oregon Health and Science University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Kansas | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2006 |
7 organizations
Page 1 / 1